Usage : Treatment of multiple myeloma Used in: Newly diagnosed multiple myeloma (with combination therapy) R
Strength : 400 mg per vial Also available in 100 mg / 5 mL vial in some markets
Material : Active ingredient: Daratumumab Type: Fully human IgG1κ monoclonal antibody Excipients: Includes stabilizers, buffers, and preservatives used for injectable biologics Form: Sterile liquid protein solut